BIOMAT Database Logo BIOMAT Database Logo

Cellular origin and lineage specificity of the JAK2(V617F) allele in polycythemia vera. 2007

Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011087 Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. Erythremia,Osler-Vaquez Disease,Polycythemia Rubra Vera,Polycythemia Ruba Vera,Primary Polycythemia,Disease, Osler-Vaquez,Erythremias,Osler Vaquez Disease,Polycythemia Ruba Veras,Polycythemia Rubra Veras,Polycythemia, Primary,Polycythemias, Primary,Primary Polycythemias,Ruba Vera, Polycythemia,Ruba Veras, Polycythemia,Vera, Polycythemia Ruba,Vera, Polycythemia Rubra,Veras, Polycythemia Ruba,Veras, Polycythemia Rubra
D006410 Hematopoiesis The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY). Hematopoiesis, Medullary,Haematopoiesis,Medullary Hematopoiesis
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D053614 Janus Kinase 2 A Janus kinase subtype that is involved in signaling from GROWTH HORMONE RECEPTORS; PROLACTIN RECEPTORS; and a variety of CYTOKINE RECEPTORS such as ERYTHROPOIETIN RECEPTORS and INTERLEUKIN RECEPTORS. Dysregulation of Janus kinase 2 due to GENETIC TRANSLOCATIONS have been associated with a variety of MYELOPROLIFERATIVE DISORDERS. JAK-2 Protein Tyrosine Kinase,JAK2 Protein Tyrosine Kinase,JAK 2 Protein Tyrosine Kinase

Related Publications

Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
JAK2 V617F allele burden in polycythemia vera: burden of proof.
April 2023, Blood,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden.
December 2021, Blood research,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
JAK2 V617F and the evolving paradigm of polycythemia vera.
June 2010, The Korean journal of hematology,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.
September 2021, Blood cancer journal,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden.
September 2007, Leukemia,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera.
January 2022, Case reports in hematology,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations.
April 2008, Blood,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
December 2007, European journal of haematology,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele.
April 2007, Experimental hematology,
Carolyn M Butcher, and Jonathon F Hutton, and Uwe Hahn, and L Bik To, and Peter Bardy, and Ian Lewis, and Richard J D'Andrea
JAK2 V617F-positive polycythemia vera accompanied by renal artery stenosis.
December 2014, Blood research,
Copied contents to your clipboard!